Severe Dengue - 15 Studies Found
| Completed |
: Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US :
|
| Completed |
: Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children :
|
| Completed |
: Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study :
|
| Completed |
: Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India :
|
| Active, not recruiting |
: Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia :
|